Journal article
HIV persistence: Chemokines and their signalling pathways
VA Evans, G Khoury, S Saleh, PU Cameron, SR Lewin
Cytokine and Growth Factor Reviews | ELSEVIER SCI LTD | Published : 2012
Abstract
Latently infected resting CD4+ T cells are the major barrier to curing HIV. We have recently demonstrated that chemokines, which bind to the chemokine receptors CCR7, CXCR3 and CCR6, facilitate efficient HIV nuclear localisation and integration in resting CD4+ T cells, leading to latency. As latently infected cells are enriched in lymphoid tissues, where chemokines are highly concentrated, this may provide a mechanism for the generation of latently infected cells in vivo. Here we review the role of chemokines in HIV persistence; the main signalling pathways that are involved; and how these pathways may be exploited to develop novel strategies to reduce or eliminate latently infected cells. ©..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
SRL is an Australian National Health and Medical Research Council (NHMRC) practitioner fellow. This work was funded by grants from the National Institutes of Health U19 AI096109 and the American Foundation for AIDS Research 108237-51-RGRL and 108023-49-RFRL.